1. Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer
   Mark B. Hampton et al, 2018, Antioxidants & Redox Signaling CrossRef
2. High expression of peroxiredoxin 4 affects the survival time of colorectal cancer patients, but is not an independent unfavorable prognostic factor
   NAN YI et al, 2014, Molecular and Clinical Oncology CrossRef
3. Silencing of Peroxiredoxin-4 in Anticancer Activity of Gamma-Tocotrienol
   Afiah Nasuha Aznan et al, 2020, Synthetic Biology - New Interdisciplinary Science CrossRef
4. Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer
   Yu-Lin Sun, 2015, World Journal of Gastroenterology CrossRef
5. Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies
   Stefania Pizzimenti et al, 2021, Antioxidants CrossRef
6. Peroxiredoxin 1 – an antioxidant enzyme in cancer
   Chenbo Ding et al, 2017, Journal of Cellular and Molecular Medicine CrossRef
7. Nicotine suppresses apoptosis by regulating α7nAChR/Prx1 axis in oral precancerous lesions
   Chunxiao Wang et al, 2017, Oncotarget CrossRef
8. Prx1 promotes the proliferation and migration of vascular smooth muscle cells in a TLR4-dependent manner
   Zhicheng Zhu et al, 2017, Molecular Medicine Reports CrossRef
9. Pluronics and MDR Reversal: An Update
   Daria Y. Alakhova et al, 2014, Molecular Pharmaceutics CrossRef
10. Metabotropic glutamate receptor 3 is involved in B-cell-related tumor apoptosis
    Xiaoling Liu et al, 2016, International Journal of Oncology CrossRef
11. FOXO1, a tiny protein with intricate interactions: Promising therapeutic candidate in lung cancer
    Mohammad Ebrahimnezhad et al, 2023, Biomedicine & Pharmacotherapy CrossRef
12. New insights into the roles of peroxiredoxins in cancer
    Yan Liu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
13. Nanotechnology approaches for personalized treatment of multidrug resistant cancers
    Tamara Minko et al, 2013, Advanced Drug Delivery Reviews CrossRef